Correlation Between Xavis and Sinil Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Xavis and Sinil Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Xavis and Sinil Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Xavis Co and Sinil Pharmaceutical Co, you can compare the effects of market volatilities on Xavis and Sinil Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Xavis with a short position of Sinil Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Xavis and Sinil Pharmaceutical.
Diversification Opportunities for Xavis and Sinil Pharmaceutical
0.49 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Xavis and Sinil is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Xavis Co and Sinil Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sinil Pharmaceutical and Xavis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Xavis Co are associated (or correlated) with Sinil Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sinil Pharmaceutical has no effect on the direction of Xavis i.e., Xavis and Sinil Pharmaceutical go up and down completely randomly.
Pair Corralation between Xavis and Sinil Pharmaceutical
Assuming the 90 days trading horizon Xavis Co is expected to under-perform the Sinil Pharmaceutical. In addition to that, Xavis is 1.7 times more volatile than Sinil Pharmaceutical Co. It trades about -0.47 of its total potential returns per unit of risk. Sinil Pharmaceutical Co is currently generating about -0.26 per unit of volatility. If you would invest 720,000 in Sinil Pharmaceutical Co on September 1, 2024 and sell it today you would lose (66,000) from holding Sinil Pharmaceutical Co or give up 9.17% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 95.65% |
| Values | Daily Returns |
Xavis Co vs. Sinil Pharmaceutical Co
Performance |
| Timeline |
| Xavis |
| Sinil Pharmaceutical |
Xavis and Sinil Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Xavis and Sinil Pharmaceutical
The main advantage of trading using opposite Xavis and Sinil Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Xavis position performs unexpectedly, Sinil Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sinil Pharmaceutical will offset losses from the drop in Sinil Pharmaceutical's long position.The idea behind Xavis Co and Sinil Pharmaceutical Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Sinil Pharmaceutical vs. Digital Power Communications | Sinil Pharmaceutical vs. Hanjoo Light Metal | Sinil Pharmaceutical vs. Shinsegae Information Communication | Sinil Pharmaceutical vs. Korea Air Svc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |